Galapagos NV Stock Euronext Bruxelles
Stocks
GLPG
BE0003818359
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 1.77B 2.02B 1.63B 1.51B 2.87B 192B 2.91B 19.58B 7.61B 94.66B 7.58B 7.42B 327B | P/E 2026 * |
-9.24x | P/E 2027 * | -10.6x |
|---|---|---|---|---|---|
| Enterprise Value | -884M -1.01B -815M -755M -1.43B -95.89B -1.46B -9.78B -3.8B -47.3B -3.79B -3.71B -164B | EV / Sales 2026 * |
-5.88x | EV / Sales 2027 * | -5.11x |
| Free-Float |
74.64% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Galapagos NV
| Manager | Title | Age | Since |
|---|---|---|---|
Henry Gosebruch
CEO | Chief Executive Officer | 53 | 13/05/2025 |
Aaron Cox
DFI | Director of Finance/CFO | 43 | 07/07/2025 |
Eric Hedrick
CTO | Chief Tech/Sci/R&D Officer | 61 | 08/06/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Linda Higgins
BRD | Director/Board Member | 63 | 22/10/2019 |
Oleg Nodelman
BRD | Director/Board Member | 49 | 07/10/2024 |
Henry Gosebruch
BRD | Director/Board Member | 53 | 13/05/2025 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 1.99B | |
| -1.03% | +5.24% | +2.94% | +9.41% | 50.25B | |
| +0.25% | +1.70% | +419.39% | +621.71% | 40.39B | |
| +1.10% | +7.77% | +28.18% | -3.96% | 34.38B | |
| -0.16% | +8.12% | +27.85% | +62.55% | 34.4B | |
| +1.31% | -0.56% | +5.12% | +33.90% | 26.32B | |
| -0.35% | +0.09% | - | - | 16.64B | |
| -3.33% | +3.15% | +71.30% | +131.94% | 16.14B | |
| +0.32% | +0.53% | +14.33% | +21.47% | 13.71B | |
| +3.79% | +8.88% | +106.63% | +106.63% | 13.75B | |
| Average | +0.16% | +4.45% | +84.47% | +122.96% | 27.33B | |
| Weighted average by Cap. | +0.05% | +5.02% | +95.76% | +141.20% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 150M 172M 139M 128M 244M 16.31B 248M 1.66B 647M 8.05B 645M 630M 27.82B | 132M 151M 122M 113M 214M 14.32B 218M 1.46B 568M 7.07B 566M 554M 24.42B |
| Net income | -261M -297M -240M -223M -422M -28.27B -429M -2.88B -1.12B -13.94B -1.12B -1.09B -48.2B | -145M -166M -134M -124M -235M -15.74B -239M -1.61B -624M -7.76B -622M -608M -26.84B |
| Net Debt | -2.65B -3.03B -2.45B -2.27B -4.3B -288B -4.37B -29.36B -11.41B -142B -11.37B -11.12B -491B | -2.44B -2.79B -2.25B -2.09B -3.96B -265B -4.03B -27.04B -10.51B -131B -10.47B -10.24B -452B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Choose MarketScreener 
